EMBRIENT INC

Medtech · Private

Continuous flow cell culture incubator with sealed chamber for stable, reproducible in vitro cell growth

Grants
$2.1M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
21
5 granted · 16 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Developing a Novel Incubator to Increase Cell Culture Reproducibility$262,240
Federal grantDepartment of Health and Human Services · Phase II · Developing a Novel Incubator to Increase Cell Culture Reproducibility$910,185
Federal grantDepartment of Health and Human Services · Phase II · Developing a Novel Incubator to Increase Cell Culture Reproducibility$908,687
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1648Akeyna Inc.—$300K
1649AGIGA, INC.—$3.6M
1650PREDICOR LLC——
1651EMBRIENT INC——
1652MICROGRADIENT FLUIDICS LLC——
1653NEOCARE INNOVATIONS, INC.——
1654TARAWA LABS INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 5 granted of 21

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.